Lakefront Biotherapeutics American Depositary Shares
LKFT
143 hedge funds and large institutions have $1.5B invested in Lakefront Biotherapeutics American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 42 reducing their positions, and 18 closing their positions.
221% more call options, than puts
Call options by funds: $80.2M | Put options by funds: $25M
38% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 42
11% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 18
1% more funds holding
Funds holding: 141 → 143 (+2)
0% more capital invested
Capital invested by funds: $1.5B → $1.5B (+$979K)
0.14% less ownership
Funds ownership: 11.82% → 11.69% (-0.14%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$45.6M |
| 2 |
Jane Street
New York
|
+$9.48M |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$6.04M |
| 4 |
BlackRock
New York
|
+$5.48M |
| 5 |
Renaissance Technologies
New York
|
+$5.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$60.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$14.9M |
| 3 |
Morgan Stanley
New York
|
-$5.82M |
| 4 |
JP Morgan Chase
New York
|
-$5.45M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.18M |
LKFT Hedge Fund Activity: Q2 2020 in Review
143 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q2 2020, worth a combined $1.5B — up 0.07% from $1.5B a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new LKFT positions and 18 closed out — a net gain of 2 holders — while 58 added to existing stakes and 42 trimmed.
The largest buyer was Capital International Investors, opening a new position worth an estimated $45.6M. The largest seller was Fidelity Investments, cutting an estimated $60.6M.
- 143 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q2 2020, up from 141 in Q1 2020.
- Funds reported $1.5B of Lakefront Biotherapeutics American Depositary Shares stock for Q2 2020, up 0.07% quarter-over-quarter.
- 20 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q2 2020 and 18 closed out, a net change of +2 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q2 2020 was Capital International Investors, an estimated $45.6M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q2 2020 was Fidelity Investments, an estimated $60.6M sold.
Based on aggregated 13F filings for Q2 2020.